First Wave BioPharma CMO James Pennington to retire, will consult until successor named

GridAI Technologies Corp.

James Pennington, M.D., Chief Medical Officer, informed company of retirement on March 31, 2022.
No disagreement with operations, policies, or practices was cited in the notice.
Pennington will transition to a consultant role until a new CMO is appointed.
Successor has not yet been announced.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

James Pennington, M.D.

Chief Medical Officer

GRDX · GridAI Technologies Corp.

Effective: 2022-03-31
Filed: April 6, 2022, 7:59 PM ET

On March 31, 2022, James Pennington, M.D., Chief Medical Officer of First Wave BioPharma, Inc. (the “Company”), informed the Company of his intention to retire as Chief Medical Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

James Pennington, M.D. retired as Chief Medical Officer at GridAI Technologies Corp..

Action: retired
Role: Chief Medical Officer

Exact text from the filing

On March 31, 2022, James Pennington, M.D., Chief Medical Officer of First Wave BioPharma, Inc. (the “Company”), informed the Company of his intention to retire as Chief Medical Officer.

View on SEC.gov

GridAI Technologies Corp. filing history →

Source: SEC EDGAR

accession 0001140361-22-013398

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.